---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-041287"
form_type: "8-K"
ticker: "SIGY"
cik: "0001642159"
company_name: "Sigyn Therapeutics, Inc."
filed_at: "2024-10-16T23:59:59+00:00"
generated_at: "2026-05-30T13:44:48.000923+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Sigyn Therapeutics exchanges 246,259 warrants for 184,699 restricted shares; no warrants outstanding

## Summary
- Exchanged 246,259 stock purchase warrants from 15 holders for 184,699 restricted common shares.
- No warrants remain outstanding; all previously issued warrants extinguished.
- Outstanding common shares increased to 1,605,377 from 1,420,678.
- Transaction exempt under Section 4(a)(2); no brokerage fees paid.

## SEC filing metadata
- accession: 0001493152-24-041287
- form_type: 8-K
- ticker: SIGY
- cik: 0001642159
- company_name: Sigyn Therapeutics, Inc.
- filed_at: 2024-10-16T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1642159/000149315224041287/0001493152-24-041287-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1642159/000149315224041287/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-041287
- JSON: https://secwatch.observer/filing/0001493152-24-041287.json
- Plain text: https://secwatch.observer/filing/0001493152-24-041287.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.